Two familiar names do not add up to a proven combination.
BPC-157 and TB-500 are frequently discussed together. That does not mean a combination has been validated for use in dogs.
Study material matters
Research involving full-length thymosin beta-4 must not be treated as automatic evidence for a product sold as TB-500. Identity, sequence and formulation matter.
Mechanism is not an outcome
A change in cell migration or a result in a rodent injury model does not establish a safe canine dose or prove that a dog will recover faster.
Our position
We are not publishing a dosing protocol, expected improvement timeline or safety claim for the proposed combination. Our research page distinguishes the available evidence from the unanswered product questions.
